IDEAYA Biosciences, Inc. (IDYA) income statement
IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$26.49−0.91 (-3.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
IDEAYA Biosciences, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -92.7%
- Net margin
- -74.8%
- Return on equity, FY2025
- -10.9%
Financial strength
- Current ratio
- 10.45
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 329.7%
Valuation
- P/E ratio
- –
- Price to sales
- 10.92
- Price to book
- 2.13
- Dividend yield
- –
See a number that looks wrong?